When the pancreas, due to mechanical issues or dysfunction, can no longer produce sufficient digestive enzymes, oral enzyme replacement becomes essential.
 
For this therapy to be truly effective, the formulation must meet three critical requirements:
 – Gastric protection : enzymes must withstand stomach acidity,
 – Targeted release : enzymes must be released immediately upon exiting the stomach,
 – Localized action : enzymes must act efficiently in the upper intestine, where nutrient absorption begins.
 
Therapeutic Goal :
Break down the food bolus rapidly and thoroughly, enabling optimal nutrient absorption.

Eneapharm is developing an innovative formulation, EN311, designed to meet all these essential criteria.
An effective and lower-dose treatment with no side effects, restoring digestive comfort and improving patients’ quality of life.